Lung deflation with indacaterol/glycopyrronium improves pulmonary microvascular blood flow in the CLAIM Study
J. Vogel-Claussen (Hannover, Germany), C. Schoenfeld (Hannover, Germany), C. Czerner (Hannover, Germany), J. Renne (Hannover, Germany), T. Kaireit (Hannover, Germany), H. Tillmann (Basel, Switzerland), K. Berschneider (Nuremberg, Germany), S. Hiltl (Nuremberg, Germany), J. Bauersach (Hannover, Germany), T. Welte (Hannover, Germany), J. Hohlfeld (Hannover, Germany)
Source: International Congress 2018 – Innovative therapies in asthma and COPD
Session: Innovative therapies in asthma and COPD
Session type: Poster Discussion
Number: 612
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Vogel-Claussen (Hannover, Germany), C. Schoenfeld (Hannover, Germany), C. Czerner (Hannover, Germany), J. Renne (Hannover, Germany), T. Kaireit (Hannover, Germany), H. Tillmann (Basel, Switzerland), K. Berschneider (Nuremberg, Germany), S. Hiltl (Nuremberg, Germany), J. Bauersach (Hannover, Germany), T. Welte (Hannover, Germany), J. Hohlfeld (Hannover, Germany). Lung deflation with indacaterol/glycopyrronium improves pulmonary microvascular blood flow in the CLAIM Study. 612
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: